Volz et al. conducted a retrospective analysis to find out more about the use of a proprietary lavender oil preparation over a longer period of time (>3 or >6 months) and to evaluate the usage behavior of 12-17-year-olds. For this purpose, they analyzed large data sets from Switzerland and Germany. The results are very informative and confirm the positive results of this widespread treatment option in a real-world setting.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Migraine: better quality of life thanks to multimodal care
Broader selection of innovative migraine prophylactics and acute therapies
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging
Mitochondrial dysfunction and energy metabolism
- Health Literacy
Promoting health literacy: from the abstract to the concrete level
- Pharmacological therapy